Feedback / Questions
orforglipron (OWL833) - Eli Lilly
Orforglipron: Regulatory submission in US/EU/Japan for obesity in 2025
(Eli Lilly)
-
Feb 7, 2025 -
Q4 2024 Results
EMA filing • FDA filing • Japan filing
•
Obesity
https://investor.lilly.com/static-files/edf26bde-58ad-4c0c-9430-7f36e64c7968
Feb 7, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious